| 10238671 |
Hydrosoluble hydroxybisphosphonic derivatives of doxorubicin |
Jean-Yves Goujon, Ronan Le Bot, Emmanuelle David |
2019-03-26 |
| 10188669 |
Mitochondria-targeted antioxidants for treatment of age-related brain disorders |
Maxim V. Skulachev, Vladimir P. Skulachev, Nikolai Konstantinovich Isaev, Nadezhda Anatolievna Kapay, Dmitry Borisovich Zorov +2 more |
2019-01-29 |
| 9744180 |
Pharmaceutical formulations containing mitochondrially targeted antioxidants |
Maxim V. Skulachev, Vladimir P. Skulachev, Egor Y Plotnikov, Dmitry Borisovich Zorov, Roman A. Zinovkin +3 more |
2017-08-29 |
| 9572890 |
Oral formulations of mitochondrially-targeted antioxidants and their preparation and use |
Maxim V. Skulachev, Vladimir P. Skulachev, Audrey A. Zamyatnin, Vadim N. Tashlitsky, Roman A. Zinovkin +4 more |
2017-02-21 |
| 9546159 |
N-substituted 3,4-bis (catechol) pyrrole compounds, and the preparation and use thereof in the treatment of cancer |
Pascal Collin, Bernard Delpech, Joanna Bakala, Maria Achab, Jérôme Bignon +2 more |
2017-01-17 |
| 9192676 |
Oral formulations of mitochondrially-targeted antioxidants and their preparation and use |
Maxim V. Skulachev, Vladimir P. Skulachev, Andrey Aleksandrovich ZAMYATNIN, Eugeny S. Efremov, Vadim N. Tashlitsky +5 more |
2015-11-24 |
| 9173946 |
Bifunctional hydroxy-bisphosphonic acid derivatives |
Jean-Yves Goujon, Ronan Le Bot |
2015-11-03 |
| 8361993 |
Hydroxy-bisphosphonic acid derivatives as vector targeting bone tissue |
Yannick Fortun, Dominique Heymann, Jacques Lebreton, Monique Mathe, Marc Padrines +1 more |
2013-01-29 |